join us at to vote on which eu leaders are sustainable -othe covid meta - eg mayo
scandals 20 years in making - how govs underinvested in basic mnra research ...also 20 years ago i was lucky to meet a professor of nature at bath uni -i am terrified by what he knows but top down medical bureaucrats dont

1 twitter smart virus lists v0 v2 ==

rsvp sources by and for all -why experts in ebola are not in covid

close encounters:
of healthy kind, of servant leader kind, of food security, of education kind, of credit kind, of solar kind, of other machine intel kind
37th year of economist debate- who will get last mile in time forpost-covid's sdg generation?- biden?, africa?, bangladesh?, far east islands, rest asia continent, euro, latinam, womens lives, colored second most exciting moment in life- meeting sir fazle abed 1 2- he had designed a rural health service for one of the ten most populous nations from scratch? which do you think sir fazle need more help from health genii or financial genii? -more here

2020 telehealth hinge moment
our biggest challenge in 2020s is not the virus it is failing to unite around designing a world so next girl or boy born has a joyful chance at a productive life- that depends on 3 skills thriving in ever community - the health servant (, the livelihood educator ( and the financial servant (
however we have known since the end of world war 2 that we need new maps than those that 8 largest empires had ruled planet with - and that 4 new technologies and types of mediation will multiply this sustainably up or crashing down until mother natures selects us as next dod- more at
who published 13 global health challenges 1/13/2020 - help update them -related search malaria : fda -messy

virus unknowns help unwomens list some twitter dialogues 1 2 3
ByeBye human race unless you can help us find medical word's top 10 World Record Jobs Creators 9 8 7 ...Ironically knowledge of the curriculum of entrepreneurial revolution - as the net generation's opportunity to collaborate in human sustainability peaked in 1984 - unless you can help World Record Jobs Creators retrieve it now - thanks chris macrae wash dc text 240 316 8157 Anyone seriously transparent about affordable global health and sustainability needs to develop segments of health services and then decide whether an integrated service is still to have place boundaries. THE BLOCKCHAIN WARS. New media is always a battle between the forces for evil who linkin fast and those who needed to open space for a deeper social order (which takes time). Understanding blockchain mapping will also be absolutely essential: it may be how sustainability's last call is won by little sisters or lost to big brothers. these are the most exciting times to be alive.. 4 markets human sustainability depends on health & . linkedin UNwomens - question collab blog editors: washington DC

china; Qatar bangladesh and asean ghana france india


good news china's robot teachers assistants will soon be better at diagnosis than 99% of docs. china

online library of norman record jobs creators: sir fazle abed .. jim kim.JKU. larry brilliant.. gerge soros..paul farmer .leana wen .BillionGirlsBoys network

Friday, June 10, 2016

Jordan Jarvis started a discussion in Young Professionals Chronic Disease Network:
---Statement by the Young Professionals Chronic Disease Network in Response to Astrazeneca CEO’s comments on free cancer drugs for Africa---
Thursday, June 9, the BBC reported that the CEO of pharma giant AstraZeneca, Pascal Soriot, announced that, when it comes to cancer in “Africa, we could give our products away and it would make no difference.”
Dr. Fidel Rubagumya, a member of the YP-CDN, a global community of over 5,000 health advocates, says that, “As someone who was trained as a medical student in Africa, practiced as a cancer treating non-oncologist medical doctor in a rural Rwanda and now training as a clinical oncologist in Africa, I found Mr. Soriot’s statements absurd and saddening.”
Soriot’s statement echoes the comment made by Bayer CEO Marijn Dekkers in 2014, that the company’s cancer medicines were made for “Western patients who can afford it”. The AstraZeneca CEO further declared that the implementation and infrastructure challenges to deliver the necessary healthcare in Africa are too great. This is an old and disproven argument that kept HIV/AIDS medicines out of the hands of patients in low resource countries prior to 2002.
Dr. Rubagumya remarks that, “Mr. Soriot has never sat with a breast cancer patient who can’t afford two meals a day to tell her that the drug she needs to survive will cost USD 1000! The patient literally laughs at you, despite the excruciating cancer and heartbreaking reality of their situation. We are starting to make progress. For example, the Rwandan Government’s work with global partners has enabled patients with cancers, such as Chronic Myeloid Leukemia, to now be treated at Butaro Cancer Center in Rwanda just as they’d be treated in Boston.”
“The message AstraZeneca is sending is that if you cannot afford to pay for exorbitant cancer drug prices, you don’t deserve treatment,” says Jordan Jarvis, YP-CDN’s Executive Director. “In 2012, the African continent saw 645,000 diagnosed new cancer cases and 456,000 cancer deaths per year. Last year, the World Health Organization added 16 new lifesaving medicines for cancer to their Model List of Essential Medicines, which guides drug procurement, reimbursement and donations worldwide. Access to cancer treatment, just like lifesaving treatment for other diseases, is a human right.”
As the humanitarian aid organization Medicins Sans Frontiers has previously stated, “Drug companies claim to care about global health needs, but their track record says otherwise.” Health advocates have been fighting for affordable medicines, mostly for infectious diseases in the global south for about two decades. Increasingly, this battle is including medicines for cancer and other chronic diseases. “With current cancer drug prices that break the bank for even the wealthiest health systems, all countries now need to stand up against drug company price gouging and R&D policies that deny life to the poor,” stated Jarvis. “This kind of medical apartheid is unacceptable from anyone in 2016, much less the head of a major drug corporation.” 

No comments:

Post a Comment